Deep dive into

Imeka lets you see white matter like you’ve never seen it before.

Come see how our imaging technology takes your research further.


Neuroinflammation. Axonal integrity. Myelin integrity. White matter health. We see all that and more—including details that others miss.

By combining advanced white matter imaging with artificial intelligence, Imeka’s ANIE (Advanced Neuro Imaging Endpoints) biomarker platform analyzes white matter pathology in greater detail than anyone else.

Learn more

Tracking and quantifying measures that matter

Imeka’s ANIE biomarker platform identifies inflammation, demyelination, and axonal degeneration and is robust to crossing fibers.

Learn more

We specialize in neurodegenerative diseases

Rely on our expertise in Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and other white matter pathologies.

Learn more

Optimize and streamline your pipeline

Learn if, how, and where in the brain your potential therapeutics are working.

Learn more

Studied and proven, with over 10 years of experience.

Imeka’s technology has benefited experts from pharmaceutical companies to researchers.

Learn more

Let’s collaborate!

Like you, our main goal is to play an influential role—and minimize risk—in the search for and development of cures for brain diseases.

Contact us